Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
Systematic reviews (SYSVAC)
Type of publications
Guidelines (30)
NITAG documentation (1591)
Reports (55)
SAGE documentation (218)
Scientific publications (112)
Systematic reviews (SYSVAC) (2750)
Regions
Africa (112)
Americas (103)
Eastern Mediterranean (27)
Europe (80)
South-East Asia (31)
Western Pacific (59)
Diseases
Chikungunya (2)
Cholera (17)
COVID-19 (1089)
Cytomegalovirus (1)
Dengue (14)
Diphtheria (34)
Ebola (3)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (28)
Hepatitis A (20)
Hepatitis B (109)
Hepatitis C (4)
Hepatitis E (3)
Herpes simplex (1)
Herpes zoster (37)
HIV / AIDS (9)
Human papillomavirus (HPV) (303)
Influenza (363)
Japanese encephalitis (7)
Lyme disease, Borreliosis (1)
Malaria (6)
Measles (77)
Meningococcal disease (34)
Mpox (25)
Mumps (32)
Pertussis (63)
Pneumococcal disease (168)
Poliomyelitis (37)
Q fever (1)
Rabies (11)
Rotavirus (71)
RSV (Respiratory syncytial virus) (14)
Rubella (41)
Salmonella (2)
Shigella (1)
Smallpox (4)
Streptococcus group B (6)
Tetanus (43)
Tick-borne encephalitis (6)
Tuberculosis (52)
Typhoid (8)
Varicella (39)
Yellow fever (18)
Zika (1)
Show more
Vaccine topics
Acceptance
Administration
Coverage
Economic aspects
Efficacy/effectiveness
Ethical issues
Logistics
Modeling
Safety
Target population
Adolescents (582)
Adults (965)
All age groups (1112)
Children (414)
Healthcare workers (343)
Newborn (331)
Older adults (612)
Parents/caregivers (240)
Pregnant women (232)
Travellers (13)
Publication date
2025 (64)
2024 (407)
2023 (499)
2022 (614)
2021 (283)
2020 (117)
2019 (93)
2018 (89)
2017 (123)
2016 (125)
2015 (100)
2014 (82)
2013 (60)
2012 (54)
2011 (40)
Show more
2750 results found
2013
∙
Peasah, S. K. Azziz-Baumgartner, E. Breese, J. Meltzer, M. I. Widdowson, M. A.
Influenza cost and cost-effectiveness studies globally - A review
2013
∙
Goossen, G. M. Kremer, L. C. van de Wetering, M. D.
Influenza vaccination in children being treated with chemotherapy for cancer
2013
∙
Eliakim-Raz, N. Vinograd, I. Zalmanovici Trestioreanu, A. Leibovici, L. Paul, M.
Influenza vaccines in immunosuppressed adults with cancer
2013
∙
Ott, J. J. Klein Breteler, J. Tam, J. S. Hutubessy, R. C. Jit, M. de Boer, M. R.
Influenza vaccines in low and middle income countries: a systematic review of economic evaluations
2013
∙
Khan, A. A. Zahidie, A. Rabbani, F.
Interventions to reduce neonatal mortality from neonatal tetanus in low and middle income countries - A systematic review
2013
∙
Mateen, F. J., Shinohara, R. T., Sutter, R. W.
Oral and inactivated poliovirus vaccines in the newborn: A review
2013
∙
Bonanni, P. Gershon, A. Gershon, M. Kulcsár, A. Papaevangelou, V. Rentier, B. Sadzot-Delvaux, C. Usonis, V. Vesikari, T. Weil-Olivier, C. De Winter, P. Wutzler, P.
Primary versus secondary failure after varicella vaccination: Implications for interval between 2 doses
2013
∙
Kersun, L. S. Reilly, A. F. Coffin, S. E. Sullivan, K. E.
Protecting pediatric oncology patients from influenza
2013
∙
Fischer Walker, C. L. Munos, M. K. Black, R. E.
Quantifying the indirect effects of key child survival interventions for pneumonia, diarrhoea, and measles
2013
∙
Rafferty, E. Duclos, P. Yactayo, S. Schuster, M.
Risk of yellow fever vaccine-associated viscerotropic disease among the elderly: A systematic review
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register